Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SA patient activists wants court to consider medicines access issue in Sanofi patent case

This article was originally published in Scrip

Executive Summary

A South African patent dispute concerning Sanofi's anticancer Taxotere (docetaxel) and Cipla's cut-price generic version of the product is expected to attract global attention, with the local HIV-focused advocacy group Treatment Action Campaign (TAC) urging the court to consider the right of access to healthcare services when it decides on the case.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts